Icariin promotes osteogenic differentiation of BMSCs by upregulating BMAL1 expression via BMP signaling

Explore this paper's citation graph

Summary

A novel target of icariin is described that has potential applications in the treatment of osteogenic disorders and promoted osteogenic differentiation through BMAL1-BMP2 signaling in BMSCs.

Type
article
Published
2020-01-20
Cited by
38
References
37
Access
Open access

Keywords

Icariin, RUNX2, Bone morphogenetic protein 2, Chemistry, Cell biology

References

Cited by

Related papers